Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi. Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy. International journal of clinical oncology. 2023
Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy, Meriem Messaoudene. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer. Current oncology (Toronto, Ont.). 2023. 30. 11. 9406-9427
Tsuyoshi Hirata, Taiki Hakozaki. Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer. Journal of thoracic disease. 2023. 15. 7. 3554-3556
Taiki Hakozaki. Quantitative spatial profiling of PD-1/PD-L1 interaction in patients with cancer. Translational lung cancer research. 2023. 12. 6. 1346-1349
Yuji Uehara, Taiki Hakozaki. Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer. Translational Lung Cancer Research. 2023. 12. 1. 6-10
分子標的治療・テクノロジー新時代のあたらしい肺癌現場診断学 = Novel diagnosis of Lung Cancer in the clinic ; Molecular Targeted Therapy and the new age of technology
南江堂 2018 ISBN:9784524255832